Tag: Viatris Inc.

Viatris Announces Five Data Presentations on Novel Fast-Acting Meloxicam (MR-107A-02) at PAINWeek 2025 Conference

Presentations to include efficacy, safety and opioid use reduction data in two different surgery models as well as pharmacokinetics data PITTSBURGH, Aug. 1, 2025 /PRNewswire/...

Viatris to Report Second Quarter 2025 Financial Results on August 7, 2025

PITTSBURGH, June 12, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS) will report second quarter 2025 financial results on Thursday, August 7, 2025. Company executives will...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Phone

This field is for validation purposes and should be left unchanged.

HomeTagsViatris Inc.

USANA’s Celavive Contouring Face & Neck Crème Named Among Canada’s Top Skincare Products

FLASH GLOBAL LAUNCHES DALLAS CENTER OF EXCELLENCE FOR DISTRIBUTION AND RETURNS OPERATIONS

Zylox-Tonbridge Recognized as Most Honored Company in Extel 2026 Asia Executive Team Survey

Tag: Viatris Inc.

Viatris Announces Five Data Presentations on Novel Fast-Acting Meloxicam (MR-107A-02) at PAINWeek 2025 Conference

Viatris to Report Second Quarter 2025 Financial Results on August 7, 2025

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us